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ABSTRACT 
Syndecan-3 (N-syndecan) is a transmembrane hepa- 
ran sulfate proteoglycan abundantly expressed in 
developing brain. In addition to acting as a corecep- 
tor, syndecan-3 acts as a signaling receptor upon 
binding of its ligand HB-GAM (heparin-binding 
growth-associated molecule; pleiotrophin), which ac- 
tivates the cortactin-src kinase signaling pathway. 
This leads to rapid neurite extension in neuronal cells, 
which makes syndecan-3 as an interesting trans- 
membrane receptor in neuronal development and 
regeneration. However, little is known about the sig- 
naling mechanism of syndecan-3. Here we have ana- 
lyzed formation of ligand-N-syndecan signaling com- 
plexes at the cell surface using fluorescence resonance 
energy transfer (FRET) and bioluminescence reso- 
nance energy transfer (BRET). We show that ligand 
binding leads to dimerization of syndecan-3 at the cell 
surface. The dimerized syndecan-3 colocalizes with 
actin in the filopodia of cells. Several amino acid 
residues (K383, G392 and G396) in the transmem- 
brane domain are shown to be important for the 
ligand-induced dimerization, whereas the cytosolic 
domain is not required for the dimerization.  
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1. INTRODUCTION 
Syndecan-3 (N-syndecan) is a transmembrane heparan 
sulfate proteoglycan (HSPG) expressed mainly in the 
nervous system [1]. Like the other members of the syn- 
decan family, the ectodomain of syndecan-3 acts as a 
receptor or co-receptor in signaling processes for a broad 
range of ligands, including FGF-2 (fibroblast growth 
factor 2) [2], HB-EGF (heparin-binding EGF like growth 
factor) [3], and GDNF (glial cell-derived neurotrophic 
factor) family neurotrophic factors [4]. One of the main 
ligands is HB-GAM (pleiotrophin), a secretory extracel- 
lular matrix-associated protein that was initially isolated 
from rat brain as a neurite outgrowth-promoting factor 
[5,6]. In the case of HB-GAM, syndecan-3 acts as a sig- 
naling receptor. Binding of HB-GAM to syndecan-3 
triggers formation of a signaling complex on the pro- 
teoglycan cytoplasmic tail, which leads to rapid neurite 
outgrowth in neuronal cells by activating the cortactin- 
src kinase signaling pathway [3,7]. However, the mecha- 
nism of HB-GAM/syndecan-3 signaling remains largely 
unexplored. 
Furthermore, syndecan-3 and HB-GAM have impor- 
tant physiological roles in limb skeletal development 
[3,7,8] and in the control of feeding behaviour [9]. They 
play a crucial role in long-term potentiation (LTP) [10, 
11], a long-lasting augmentation of synaptic strength that 
has been used as a cellular model for learning and mem- 
ory. 
Receptor dimerization is a crucial biological mecha- 
nism for receptor activation and regulation of signal 
transduction. Activation of receptor tyrosine kinases and 
other receptors that contain a single transmembrane do- 
main is known to occur through dimerization in response 
to ligand binding [12-15]. Syndecans can form SDS- 
resistant dimers and for syndecan 2 and 4 dimerization is 
implicated in receptor activation [16]. Although synde- 
can-3 dimerization was proposed to be involved in vari- 
ous signaling processes [17,18], its involvement in ligand 
binding and signal transduction has not been directly 
demonstrated before (Table S1). 
Biochemical analyses, such as covalent cross-linking 
experiments or size exclusion chromatography can iden- 
tify potential protein-protein interactions [19]. Such kind 
of approaches have been previously used for studying 
syndecan-3 dimerization (Table S1). Nevertheless, they 
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are not suitable to study interactions in living cells. 
Fluorescence resonance energy transfer (FRET) micros-
copy adapted to different-colour fluorescent protein tags 
(e.g. CFP and YFP) [20] offers the opportunity to study 
the behaviour and spatial interaction of the tagged pro-
teins in their natural environment in the living cell. Bio-
luminescence resonance energy transfer (BRET) is based 
on a similar principle but it utilizes bioluminescence 
rather than fluorescence and because of more robust sig-
nal provides means to simultaneously analyze multiple 
conditions, allowing simple and efficient screening.  
We have used both FRET and BRET techniques to 
study syndecan-3 dimerization and show for the first 
time directly that syndecan-3 dimerizes at the surface of 
live cells upon binding of its ligand HB-GAM that has 
been shown to induce a cytoplasmic signalling complex 
that associates to syndecan-3. We have designed various 
syndecan-3 constructs to clarify the role of specific se- 
quences in syndecan dimerization. A role of some amino 
acid residues in dimer formation has been previously 
assumed. However, previous research in this field has 
neglected to consider a full-length syndecan and dimeri- 
zation that could be induced by ligand binding. All stud- 
ies were done by gel filtration chromatography and 
SDS−PAGE using short transmembrane peptides or core 
proteins. Using single amino acid mutants in the trans- 
membrane domain, we have now shown for the first time 
their requirement for ligand-induced dimerization. More- 
over we show that the cytoplasmic domain of syndecan-3, 
albeit critical for cytoskeleton association and cytoplas-
mic signalling, is not required for dimerization.  
2. MATERIALS AND METHODS 
2.1. DNA Constructs 
The pECFP-EYFP plasmid with 23-amino acid linker 
has been used as FRET positive control. This construct 
was made by insertion of 800 bp AgeI-MfeI restriction 
fragment of pEYFP-C1 (Clontech) to pECFP-C1 plasmid 
in XmaI/MfeI restriction sites. Cotransfected pECFP and 
pEYFP vectors were used as negative controls.  
Rat syndecan-3 cDNA was labeled by CFP/YFP se- 
quence right after the transmembrane domain of the re- 
ceptor in the cytosolic part (amino acids Tyr409/Arg410). 
Flexible amino acid linker sequence of 2, 5 or 6 amino 
acids was left between the receptor and the fluorophore 
(Figure S1(a)). 
To express CFP/YFP-labeled syndecan-3 without cy- 
toplasmic tail syndecan was tagged with CFP/YFP in a 
similar manner as described above for the full-length 
receptor. Stop codons were inserted just after the se- 
quences encoding the CFP/YFP to delete the whole cy- 
toplasmic tail (N-syn-cyt-CFP and N-syn-cyt-YFP).  
pGFP2-Rluc(h) (PerkinElmer) plasmid has been used 
as positive BRET control and also as a source for clon- 
ing all BRET constructs. GFP2/Rluc labeling of synde- 
can-3 and its mutants has been done in the same position 
as for CFP/YFP-constructs (Figure S1(b)). 
Site-directed mutagenesis of syndecan-3 was done by 
using the following primers: 
For K383A 
CAGAAGAGCATACTAGAGCGGGCGGAGGTGC- 
TCGTAGCTGTGAT 
ATCACAGCTACGAGCACCTCCGCCCGCTCTAG- 
TATGCTCTTCTG 
For G392L, G396L 
TAGCTGTGATCGTACTTGGCGTGGTGCTCGCC- 
CTCTTCGCTGCCTT 
AAGGCAGCGAAGAGGGCGAGCACCACGCCA- 
AGTACGATCACAGCTA 
2.2. Cell Culture and Transfection 
HEK293T cells were grown in 35-mm glass bottom cul- 
ture dishes (MatTek) in DMEM medium (Invitrogen), 
supplemented with 10% FCS (Invitrogen), L-glutamine 
and penicillin-streptomycin at 37˚C in 5% CO2. Petri 
dishes were coated by poly-L-lysine (20 µg/ml), HB- 
GAM (50 µg/ml), laminin (10 µg/ml) or BSA (100 
µg/ml). 
B-27 supplemented Neurobasal medium was used for 
culturing E17-18 hippocampal primary neurons isolated 
as described previously [4]. Hippocampal primary neu- 
rons were transfected by electroporation with Nu- 
cleofector Device (Amaxa) and Rat Neuron Nucleofector 
Kit using standard protocol (O-03 or G-13 programs). 
Transfection of HEK293T cells was done by Fugene6 
(Roche) and JetPei (Polyplus Transfection) transfection 
kits. 
2.3. Western Blot Analysis 
Whole cell lysate of HEK293T cells which expressed 
syndecan mutants were resolved by 4% - 15% SDS- 
PAGE. Cells were deglycosylated at 37˚C by 30 min 
incubation with heparinase I and III (H2519, H8891, 
Sigma-Aldrich) in PBS, 1 mM CaCl2. Western-blot 
semidry transfer was carried out in 10% methanol trans- 
fer buffer (30 mM Tris, 250 mM glycine, 0,01 % SDS) at 
15 V for 30 min. Subsequent staining was done by anti 
syndecan-3 antibodies (sc-9496, Santa Cruz) with dilu- 
tion 1:200. 
2.4. FRET Imaging and Analysis 
FRET imaging was performed essentially as described 
previously [3]. 12 - 24 hours after transfection with CFP- 
and YFP-tagged constructs cells were washed with se-  
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rum-free medium and incubated overnight without serum. 
Imaging was done at lower temperature 22˚C - 24˚C to 
reduce the movements of cellular organelles [20]. Solu- 
ble HB-GAM (10 - 50 ng/ml) or HB-GAM pre-coated 
4.5 µm polystyrene beads (Polysciences) were added to 
the culture dishes followed by incubation and the images 
were then acquired in different time scale. 
FRET signal was quantified with three filter sets 
(Chroma): CFP channel (EX436/20, DCLP455, EM480/ 
40); FRET channel (EX436/20, DCLP 455, EM535/30); 
YFP channel (EX500/20, DCLP515, EM535/30). Images 
were recorded in live transfected cells in CellR (Olym- 
pus) platform. The images were acquired in binning 2 × 
2 modes, to increase the signal-to-noise ratio, and 300 - 
500 ms integration times.  
The background subtraction was made prior to the 
FRET calculations. All FRET images were corrected for 
crosstalk between CFP and YFP channels using linear 
spectral unmixing algorithm [20]. Corrected FRET (Fc) 
was calculated with the following formula: 
Fc = FRET – a*CFP – b*YFP 
Correction factors were determined from separately 
expressed CFP or YFP cells: for each fluorophore the 
emission from the FRET channel was divided by the 
emission measured with either the CFP or YFP channels. 
Correction factors a and b were found to be for HEK- 
293T cells 0.39 ± 0.009 (n = 30) and 0.022 ± 0.002 (n = 
30) respectively, and for primary neurons 0.3975 ± 
0.0537 (n = 12) and 0.0281 ± 0.0053 (n = 8).  
The FRET-corrected images were transformed in 
pseudocolor mode to visualize high (shown in red) and 
low (shown in blue) values of FRET. 
2.5. BRET2 Assay 
HEK293T cells were harvested 24 or 48 hours after 
transfection with syndecan-3 constructs tagged with Rluc 
and GFP2 followed by washing with D-PBS buffer (PBS 
supplemented with 1mM CaCl2, 1 mM MgCL2 and 0.1% 
glucose). The cells were then transferred to pre-coated 
white 96-well microplate (OptiPlate-96, Perkin-Elmer) 
in the same buffer in 50 µl/well volume. To get suitable 
level of luminescence and to avoid non-specifically in- 
creasing BRET2 signal the total amount of cells was in 
the range 50,000 - 100,000 cells per well [22]. 96-well 
plates were pre-coated with different substrates: HB- 
GAM (10, 100 µg/ml), poly-L-lysine (20 µg/ml), BSA 
(100 µg/ml), b-FGF (2 µg/ml), GDNF (20 µg/ml), 
laminin (10 µg/ml) at +4˚C overnight. Cells were incu- 
bated on the plates for varying intervals ranging from 15 
- 240 minutes. After that 50 µl of 10 µM DeepBlueC 
Coelenterazine substrate was added by dispenser module 
to each well followed by measurements of signal in 
410/80 nm (Rluc) and 515/30 nm (GFP2) filters in VIC- 
TOR3 Multilabel Plate Reader (Perkin-Elmer). BRET2 
signal was calculated as a ratio of emission at 515 nm 
(minus background) to emission at 410 nm (minus back- 
ground). Background is defined as a signal of non- 
transfected cells in the respective channel. 
2.6. Actin Staining and Fluorescent Imaging 
HEK293T cells expressing YFP fusion full-length and 
cytoplasmic tail lacking syndecan-3 (NS-YFP and N- 
syn-cyt-YFP) constructs were used in actin colocaliza- 
tion experiments. Transfected cells were transferred to 
plates with different pre-coated substrates and subse- 
quently fixed in 4% formaldehyde and stained by phal- 
loidin-rhodamin. Images were recorded in two channels: 
TRITC (EX540/25, DCLP560, EM605/55) and YFP 
(EX500/20, DCLP515, EM535/30). 
3. RESULTS AND DISCUSSION 
3.1. FRET Shows Dimerization of Syndecan-3 at  
the Cell Surface 
HEK293T cells co-expressing two types of full-length 
syndecan-3 constructs (CFP and YFP fusion proteins) 
were plated on glass cover slips coated with different 
ligands. Cells grown on HB-GAM-coated surface (Fig- 
ure 1(b)) show after 4 hours of incubation clearly higher 
FRET signal compared to BSA-coated controls (Figure 
1(a)). Signal from cells on BSA surface could be ex- 
plained by basal, ligand-independent syndecan-3 dimeri- 
zation. Syndecan-3 lacking the C-terminal cytoplasmic 
part has similar levels of FRET signal (Figure 1(c)), 
showing that the cytoplasmic domain of syndecan-3 is 
not required for dimerization. This mutant stimulates 
filopodia formation and FRET signal is clearly visible in 
the cellular processes. Addition of soluble HB-GAM also 
stimulates syndecan-3 dimerization, as evidenced by the 
increase of FRET signal (Figure 1(c)). 
We have repeated our FRET experiments in 2 weeks 
old hippocampal primary neurons. To provide sufficient 
expression levels for FRET measurement, neurons were 
transfected by electroporation with fluorescently labelled 
syndecan-3 constructs. To show ligand-dependent speci- 
ficity of FRET signals, dimerization was induced by 
HB-GAM coated beads. The FRET signal accumulates in 
places where the beads contact hippocampal neurons 
(Figure 2(a)). 
In FRET analysis it is critical to subtract all crosstalks 
between fluorophores. The absence of false positive val- 
ues in negative controls confirm that the correction fac- 
tors were calculated correctly while positive controls 
expressing pCFP-YFP show maximum FRET signal 
(Figures 1(e) and 2(b)). 
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Figure 1. FRET images of HEK293T cells expressing synde- 
can-3 under different conditions. (a), (b) Cells plated on BSA (a) 
and HB-GAM (b) coated culture dishes after 4 hours of cultur-
ing. Full length syndecan-3 (NS-CFP/YFP-cd) constructs were 
used in this experiment. (c) Cells expressing a cytoplasmic tail 
deletion variant of syndecan-3 (NS-CFP/YFP-∆cd) on HB- 
GAM coated substrate after 60 minutes of incubation. (d) 
HEK293T cells expressing a full-length syndecan-3 after addi- 
tion of soluble HB-GAM. (e) Control constructs expressed in 
HEK293T cells. Positive control cells expressed pCFP-YFP 
plasmid with 23 amino acid linker, for negative control, cells 
were cotransfected with pECFP and pEYFP vectors. FRET 
corrected images are shown in pseudocolor mode to transform 
the input data into a more visible output format. High values of 
FRET signal are shown in red and low values shown in blue. 
Bars—10 µm. 
3.2. Ligand Screening by BRET Assay 
We have used the BRET assay for quantitative compari- 
son of dimerization induced by different ligands. The 
BRET assay is widely used for studying ligand-induced 
conformational changes and/or dimerization of receptors 
as well as for searching of new ligands and new drug 
leads [23-25]. In our studies we applied the second gen- 
eration of BRET assay, BRET2, based on using of GFP2 
and DeepBlueC Coelenterazine substrate which give a 
lower background and much better separation of donor 
(RLuciferase construct) and acceptor (GFP2 construct) 
signals. 
 
Figure 2. FRET images of 2 weeks old hippocampal neurons 
expressing fluorescently labeled syndecan-3 constructs after 
addition of HB-GAM coated beads. (a) Hippocampal neurons 
expressing FRET constructs after 10 and 20 min of incubation 
with HB-GAM-coated beads (stars). (b) Control constructs 
expressed in neurons. Negative and positive control cells were 
transfected as indicated in the legend for Figure 1(e). Bars—20 
µm. 
 
Similar to the FRET analysis, the BRET2 assay shows 
that ligand-induced syndecan-3 dimerization occurs upon 
plating of cells on HB-GAM-coated plates. In addition, 
there is significant increase in BRET ratio for bFGF- 
coated wells (Figure 3(a)). Previously published data 
suggests that glial cell line-derived neurotrophic factor 
(GDNF) can interact with heparan sulphate proteogly- 
cans on cell surface or in extracellular matrix and that 
heparan sulphates are required as co-receptors for GDNF 
signalling [26,27]. We have shown recently by FRET 
that GDNF induces syndecan-3 dimerization [4], there- 
fore we also included GDNF in the current screening. 
GDNF induced dimerization to the same degree as the 
established ligand HB-GAM. All control proteins (BSA, 
laminin, poly-L-lysine) which were used in this assay 
were similar to the blank BRET-ratio values (Figure 
3(a)).  
BRET was used to assay the kinetics of changes in 
syndecan-3 dimerization upon HB-GAM binding. The 
highest signal was obtained after 15 minutes of incuba- 
tion. The signal then decreased but was still detectable 
above background even up to 4 h (Figure 3(b)). 
3.3. BRET Assay of Transmembrane Domain  
Mutants 
It has been previously suggested that substitutions of 
some amino acid residues (K383, G392 and G396) from 
the transmembrane domain could inhibit syndecan-3 
self-association in vitro [17]. Gel electrophoresis and size   
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Figure 3. BRET2 analysis of ligand-induced dimerization of syndecan-3. (a) Screening of different ligands (24 
hours after transfection with Rluciferase-syndecan-3 and GFP2-syndecan-3). Plates were pre-coated at the follow-
ing concentrations: HB-GAM (10 µg/ml), poly-L-lysine (20 µg/ml), BSA (100 µg/ml), b-FGF (2 µg/ml), GDNF 
(20 µg/ml), laminin (10 µg/ml). Transfected cells were incubated on the plates for 15 minutes and BRET ratio 
measured. P-values lower than 0.05 (n = 8) are indicated with asterisk. (b) Kinetics of HB-GAM-induced dimeri-
zation of syndecan-3 (24 hours after transfection). P-values lower than 0.05 (n = 12) are indicated with asterisk. (c) 
Impaired dimerization of syndecan-3 transmembrane mutants. Cells were transfected with wild type or mutant 
syndecan-3 constructs for 48 hours to achieve sufficient level of expression for the mutants. After 15 min incuba-
tion with HB-GAM coated plates BRET ratio was measured showing significantly lower level of mutant dimeriza-
tion compared to the wild-type protein. P-values lower than 0.05 (n = 12) are indicated with asterisk. 
 
exclusion chromatography of E. coli expressed MBP- 
syndecan-3 fusion proteins was used in these studies to 
demonstrate the residue involvement in dimerization but 
the role of ligand stimulation was not determined. 
We therefore applied the BRET2 assay to test whether 
these amino acid residues are involved in ligand-induced 
dimerization in live cells, using K383A and G392L/ 
G396L mutants of syndecan-3 cloned in BRET-con- 
structs. To check that all GFP/Rluc variants of the syn- 
decan-3 mutants are expressed at similar levels, they 
were transfected to HEK293T cells and compared to 
syndecan-3 wild-type fusion proteins by western-blot 
analysis (Figure S2(a)). Correct localization was verified 
by fluorescent imaging of GFP-fused mutants and wild- 
type syndecan-3 (Figure S2(b)). All mutant proteins 
localized on the surface of cells similar to the wild type. 
In addition, tiny networks of fluorescently labeled pro-
teins were observed which may correspond to colocali-
zation with the actin cytoskeleton as it was shown pre-
viously for syndecan-3 [28,29] as well as for other syn-
decans [30-32]. 
Finally, the mutants and wild-type syndecan-3 were 
screened by BRET2 assay to check the role of K383, 
G392 and G396 amino acid residues in ligand-induced 
dimerization. The HEK293T cells were grown for 48 h 
after transfection to get sufficient level of expression. 
HB-GAM stimulated dimerization of wild type syn- 
decan-3 but both mutant variants (K383A and G392L/ 
G396L) had statistically significantly lower BRET-ratio 
signals in the presence of HB-GAM (Figure 3(c)) as 
well as on poly-L-lysine, indicating their diminished 
ability to dimerize. 
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3.4. Syndecan-3—Actin Colocalization 
BRET and FRET experiments show that HB-GAM-in- 
duced dimerization of syndecan-3 occurs mainly within 
the first 20 minutes. This data corresponds well to syn- 
decan—actin colocalization. HEK293T cells plated on 
HB-GAM show very high colocalization of syndecan 
and actin within the first 30 minutes (Figure 4(a)) com- 
pared to cells growth on BSA that do not show colocali- 
zation (Figure 4(d)). After 4 h, colocalization can mainly 
be found in cellular processes (Figure 4(b)). The cyto-
plasmic tail deletion variant of syndecan-3 does not show 
any colocalization with actin (Figure 4(c)). 
4. CONCLUDING REMARKS 
Syndecans are generally suggested to function as co- 
receptors, sequestering growth factors in extracellular 
matrices and on the cell surface locations for presenta- 
tion to signaling receptors. However, our previous stud- 
ies have suggested that syndecan-3 may act as an inde- 
pendent signaling receptor activating the cortactin-src 
kinase pathway upon binding of HB-GAM [3,7]. 
It has been well established that many signaling re-
ceptors, such as tyrosine kinase receptors, dimerize at the 
cell surface upon ligand binding which is the key event 
to trigger signal transduction. The ability of syndecans to 
form (SDS-resistant) dimers has been documented and 
for syndecan-2 and -4, and the ability to form dimers has 
been linked to their activation [16,33]. We have eluci-
dated in this study behavior of syndecan-3 at the cell 
surface upon HB-GAM binding using FRET and BRET 
to detect syndecan-3 dimerization in live cells. We dem-
onstrate that syndecan-3 is clearly dimerized upon 
HB-GAM binding, resembling the behavior of well- 
known signaling receptors such as transmembrane tyro-
sine kinases. Furthermore, mutant forms of syndecan-3 
show that the transmembrane domain, but not the cyto-
solic domain, is required for ligand-induced dimerization. 
Time range of the observed dimerization, peaking at 15 
minutes, agrees well with the formation of the kinase 
signaling complex on the syndecan-3 cytoplasmic tail, 
which was reported at 20 min after HB-GAM stimula-
tion [7]. It is unclear at the present what is the exact 
role of dimerization in the signaling process. For trans- 
 
(a) 
(b) 
(c) 
(d) 
 
Figure 4. Syndecan-3-Actin colocalization. (a) HEK293T cells plated on HB-GAM-coated 
culture dishes for 30 minutes. YFP fusion full-length syndecan-3 (NS-YFP) construct colocal- 
ized with actin on the plasma membrane. Bars—10 µm. (b) Cells transfected with the NS-YFP 
construct were plated on HB-GAM-coated culture dishes for 4 hours. Colocalization occurs 
mainly in the cellular processes. Bars—2 µm. (c) Cytoplasmic tail deletion variant of synde- 
can-3 (NS-YFP-∆cd) was expressed in HEK293T cells and cells were fixed and stained after 4 
hours of incubation on HB-GAM-coated glass. Bars—2 µm. (d) Cells expressing NS-YFP 
plated on BSA-coated cover slips after 30 minutes. Bars—10 µm. A-D: Syndecan-3-YFP fu- 
sion protein is shown in green and actin filaments stained with Alexa Fluor 568 phalloidin are 
shown in red. Merged images are shown in the right column.    
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membrane kinase receptors, dimerization brings the 
advantage of cross-phosphorylation. For syndecans, it 
could be clustering and forming a platform for facili- 
tating interactions with cytoskeleton and multiple cyto- 
plasmic signaling molecules. 
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SUPPLEMENTARY MATERIAL 
Table S1. Methods used to study homo- or heterodimerisation of syndecans. 
Syndecan family receptors Detection methods References 
Syndecan-1 Western blot with Syndecan-1 antibodies Carey D.J. et al., 1994 
Syndecan-2 SDS-PAGE of GST-syndecan-2 fusion protein Sungmun Choi et al., 2005 
Syndecan-3 
Gel filtration chromatography of fusion proteins expressed E. coli 
(MBP-N-Syndecan) 
 
SDS-PAGE of cross-linked proteins overexpressed in HEK 293T cells 
Asundi V.K. and Carey D.J., 
1995 
 
Thorsten Kirsch et al., 2002 
Syndecan-4 Gel filtration chromatography and SDS-PAGE of core protein and  synthetic peptides Eok-Soo Oh et al., 1997 
Homotypic and heterotypic 
interactions TOXCAT Assay and SDS-PAGE of short transmembrane peptides (20-21 a.a.) 
Ian C. Dews and Kevin R. 
MacKenzie, 2007 
 
 
(a) 
 
(b) 
Figure S1. Schematic representation of N-syndecan fusion 
constructs. (a) Constructs used in FRET-imaging experiments. 
CFP and YFP were linked right after the transmembrane part 
(shown as a black rectangle) of N-syndecan. The extracellular 
region (with heparan sulfate chains) and the cytoplasmic tail 
are shown as grey and unfilled rectangles respectively. (b) N- 
syndecan-GFP2/Rluc fusion proteins that were used in BRET2 
assay experiments. Mutations of N-syndecan are shown by 
arrowheads; K383A in juxtamembrane is depicted as black 
arrowhead and the mutations in the transmembrane part 
(G392L, G396L) are represented by white arrowheads. 
 
(a) 
 
(b) 
Figure S2. (a) Western-blot analysis of whole cell lysates of 
HEK 293T cells transfected with syndecan mutants using anti 
N-syndecan antibodies (sc-9496, Santa Cruz). Both mutant 
variants are expressed at similar level compared to the wild 
type protein. (b) Control of localization by fluorescent imaging 
of GFP-fused mutants and wild-type N-syndecan. WG2, WL- 
wild type N-syndecan fusion proteins with GFP2 or Renilla 
luciferase (Rluc); KG2, KL-K383A mutants of N-syndecan 
fused with GFP2 and luciferase; GG2, GL-G392L mutants of 
N-syndecan fused with GFP2 and luciferase. 
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